Datavault AI Inc. (NASDAQ:DVLT) Announces a Distribution Date of February 21, 2026 for Warrants to Purchase Common Stock to Eligible Record Equityholders of Datava…

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 7, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the ...

Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Jefferies, TD Cowen and Piper Sandler are acting as joint book-running managers for the offering. Wedbush PacGrow and LifeSci Capital are acting as passive bookrunners for this offering.

Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants

Guggenheim Securities and Cantor are acting as joint bookrunning managers for the offering. Raymond James, Needham & Company, H.C. Wainwright & Co. and Craig-Hallum are acting as co-managers for the ...

Datavault AI announces dividend of warrants

Datavault AI (DVLT) on Monday announced a proposed dividend of warrants to holders of common stock and certain other equity ...
TipRanks on MSN

Citius files to sell shares of common stock underlying warrants for holders

The filing relates to the sale or other disposition from time to time of (i) up to 21.66M shares of common stock issuable upon the exercise of ...
Nasdaq

Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI) today announced the pricing of its underwritten public offering of 9,142,857 shares of its common ...
The Manila Times

Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that it intends ...